Stock listing
600664 Stock Price, News, Filings & Events — Harbin Pharmaceutical Group Co., Ltd. Class A
Selected listing: 600664 · SSE · CNY · CN
600664:SSE is the primary listing for Harbin Pharmaceutical Group Co., Ltd. Class A, a significant player in China's pharmaceutical sector with a market capitalization of approximately 1.84 billion USD. The company specializes in the development and production of a wide range of healthcare products. Recent news and filings highlight its ongoing commitment to advancing healthcare solutions within the Chinese market, reflecting its role in addressing the evolving needs of consumers and healthcare providers.
- Ticker
- 600664:SSE
- Asset type
- Stock
- Market cap
- $2.07B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY
Harbin Pharmaceutical Group Co., Ltd. Class A 600664:SSE stock context
600664:SSE is the primary listing for Harbin Pharmaceutical Group Co., Ltd. Class A, a significant player in China's pharmaceutical sector with a market capitalization of approximately 1.84 billion USD. The company specializes in the development and production of a wide range of healthcare products. Recent news and filings highlight its ongoing commitment to advancing healthcare solutions within the Chinese market, reflecting its role in addressing the evolving needs of consumers and healthcare providers.
Research Harbin Pharmaceutical Group Co., Ltd. Class A
Harbin Pharmaceutical Group Co., Ltd. Class A investor report
Review AI stock analysis and investor report context for 600664:SSE.
Harbin Pharmaceutical Group Co., Ltd. Class A company profile
View the public company page for Harbin Pharmaceutical Group Co., Ltd. Class A on 6ix.
Harbin Pharmaceutical Group Co., Ltd. Class A news
Read company news and market updates connected to Harbin Pharmaceutical Group Co., Ltd. Class A.
Harbin Pharmaceutical Group Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Harbin Pharmaceutical Group Co., Ltd. Class A.